BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2012
View Archived Issues
New immunoreactive protein leads to statistically significant decrease in E. muris bacterial load
Read More
Wnt signaling implicated in alopecia
Read More
Second germline SUFU mutation linked to Gorlin syndrome
Read More
Daiichi Sankyo presents in vitro and in vivo data for DS-7423
Read More
Chemokine CXCR7 receptor antagonist CCX-662 tested in glioblastoma model
Read More
Galapagos selects candidate drug from new class of antibiotics
Read More
Baylor College of Medicine presents new DNA vaccines
Read More
First-in-human trial of a new class of DNA repair inhibitors
Read More
Preclinical assessment of a novel bispecific antibody for the treatment of prostate cancer
Read More
New CDK8 inhibitors designed for the treatment of colorectal cancer
Read More
Janssen presents novel salts of a PDE10 inhibitor
Read More
Researchers at Galapagos disclose novel tyrosine-protein kinase inhibitors
Read More
New therapeutic nuclease compositions prepared at University of Washington
Read More
Sanofi patents novel P2Y12 receptor antagonists
Read More
Immune Design divulges new vaccines for HSV-2 infection
Read More
Bristol-Myers files for additional Hydrea indication in Japan
Read More
Chugai and Nippon Shinyaku agree on GA-101 development for NHL in Japan
Read More
Santen files for DE-114 approval in Japan
Read More
Meiji Seika Pharma launches Diacomit for Dravet syndrome in Japan
Read More
Oculus Innovative Sciences plans new subsidiary for anti-infective drug assets
Read More
MorphoSys and Lanthio Pharma agree to develop new class of therapeutic peptides
Read More
Isotechnika receives FDA clearance to commence phase III voclosporin trial
Read More
Adcetris receives FDA orphan drug designation for mycosis fungoides
Read More
Amitiza launched in Japan for chronic constipation
Read More
Prana completes enrollment in phase II trial of PBT-2 in Alzheimer's
Read More
New European approval for Humira in severe active pediatric Crohn's disease
Read More
Eylea for wet AMD approved in E.U., launched in Japan
Read More